RightAnswer Knowledge Solutions Search Results for Teniposide

New Search  |  Search Results (Teniposide)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp

All Other Data Sources:

CCRIS Documentshelp
DART Documentshelp
GENE-TOX Documentshelp
• VM 26
HSDB® Data Bankhelp
LOLI® Listingshelp
REPROTOX® Documentshelp
RTECS® Registryhelp
Shepard's Cataloghelp

ChemID External Links:

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for Teniposide:

Please note: this is an extract of information from a larger document. Full document and details are available by subscription.


    1. Myelosuppression is the dose-limiting toxicity and a frequent occurrence with teniposide therapy. Other adverse effects that may commonly occur with teniposide therapy include nausea, vomiting, mucositis, and diarrhea. Hypersensitivity reactions, consisting of chills, fever, tachycardia, flushing, bronchospasm, dyspnea, and blood pressure changes (hypotension or hypertension), and transient hypotension following rapid intravenous administration have been infrequently reported in pediatric patients.
    1. Teniposide overdose information is limited. Severe myelosuppression is the anticipated effect following overdose. Hypotension, metabolic acidosis and somnolence have been reported after 3 to 5 tomes the usual therapeutic dose.
© 2011-2021 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.